402 F.Supp.3d 728
N.D. Cal.2019Background
- Plaintiffs (44 individuals from 22 states) allege JUUL designed and marketed JUUL e-cigarette and pods to target youth, using tobacco-industry "playbook," viral social media, flavors, influencers, POS and events, producing a youth vaping "epidemic."
- Central factual allegations: JUUL pods use a nicotine-salt/benzoic-acid formulation that (plaintiffs say) contains higher nicotine concentration than advertised and delivers nicotine faster and with less throat irritation — increasing addictiveness and absorption compared to cigarettes.
- Plaintiffs assert a nationwide class and multiple subclasses, bringing claims for false advertising, fraud, unjust enrichment, product liability (design/manufacturing/failure-to-warn), negligence, Magnuson-Moss, breach of express/implied warranty, and state consumer-protection claims.
- Procedural posture: JUUL moved to dismiss the Consolidated Amended Complaint and to compel arbitration for several named plaintiffs. The court granted dismissal in part, denied in part, denied arbitration, and allowed discovery to proceed.
- Key holdings in brief: advertising-based claims about JUUL’s pharmacokinetics survive; many fraud-based claims fail for inadequate specificity under Rule 9(b) for most plaintiffs; express warranty and negligence-per-se dismissed (no leave to amend); implied warranty, product defect (design/manufacturing), failure-to-warn (for some plaintiffs), UCL unlawful/unfair theories survive; arbitration was not enforceable because plaintiffs lacked inquiry or actual notice.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Preemption: labeling vs advertising (TCA/FDCA) | Plaintiffs: claims target advertising/omissions about nicotine pharmacokinetics, not preempted labeling claims | Juul: TCA preempts labeling-based claims and POS display theories | Court: advertising-based claims and claims about nicotine strength/pharmacokinetics are not preempted; labeling-only claims previously dismissed remain limited |
| Rule 9(b) fraud/false-advertising specificity | Plaintiffs: representative sample ads + appendix suffice; omission claims need relaxed "where" pleading | Juul: many plaintiffs failed to identify which specific ads/statements they saw | Court: plaintiffs plead who/what/when/how adequately re: pharmacokinetics, but only 12 named plaintiffs identified specific ads with sufficient particularity — other plaintiffs’ fraud claims fail for lack of "where" |
| Product liability (design/manufacturing/failure-to-warn) | Plaintiffs: design (nicotine salt, flavors, low throat hit, concealability) made product more addictive than necessary; warnings omitted about pharmacokinetics; minors especially affected | Juul: nicotine and flavors are inherent product features, not defects; FDA/regulation displace state claims; no duty beyond FDA labeling; consumer expectation/risk-utility not properly alleged for all states | Court: design and manufacturing defect claims survive (plausibly more addictive than necessary); failure-to-warn and implied warranty survive in part (for plaintiffs who allege reliance/identified ads); negligent marketing claim dismissed as subsumed; negligence-per-se dismissed |
| Arbitration (website Terms & Conditions) | Plaintiffs: no actual or inquiry notice of arbitration link on JUUL sign-up; no assent | Juul: users agreed to Terms and Conditions (click/sign-up) which include arbitration | Court: form was a sign‑in wrap but hyperlink to Terms was inconspicuous (earlier and later sign-up versions); no inquiry or actual notice — arbitration denied for the named plaintiffs at issue |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (U.S. 2007) (pleading must state a plausible claim)
- Ashcroft v. Iqbal, 556 U.S. 662 (U.S. 2009) (factual allegations must permit reasonable inference of liability)
- Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097 (9th Cir. 2003) (Rule 9(b) requires particularity for fraud claims)
- Lifescan, Inc. v. Premier Diabetic Servs., Inc., 363 F.3d 1010 (9th Cir. 2004) (arbitration analysis: existence and scope of agreement)
- Moses H. Cone Mem’l Hosp. v. Mercury Constr. Corp., 460 U.S. 1 (U.S. 1983) (doubts as to arbitrability resolved in favor of arbitration)
- Specht v. Netscape Commc’ns Corp., 306 F.3d 17 (2d Cir. 2002) (conspicuousness of online contract terms is required for assent)
- Nguyen v. Barnes & Noble Inc., 763 F.3d 1171 (9th Cir. 2014) (browsewrap vs clickwrap: notice is key to enforceability)
- Meyer v. Uber Techs., Inc., 868 F.3d 66 (2d Cir. 2017) (hybrid/sign-in wrap enforceability turns on reasonable notice of terms)
- Mangini v. R.J. Reynolds Tobacco Co., 21 Cal. Rptr. 2d 232 (Cal. Ct. App. 1993) (targeting youth in tobacco ads may support UCL unfairness claim)